CVS Health CVS shares have rallied nearly 38% so far this month, driven by the company’s stronger-than-expected first-quarter ...

The market reaction came as Trump signed a wide-ranging executive order aimed at slashing prescription drug prices in the US.

Diversified healthcare company CVS Health (NYSE:CVS) announced in Q1 CY2025, with sales up 7% year on year to $94.59 billion.

CVS Health shares powered 7% higher Thursday after the pharmacy and healthcare giant's first-quarter results easily topped ...

The deal could expand access to its in-demand obesity drug at the expense of Eli Lilly, whose shares fell by double digits on ...

CVS Health (CVS) closed the most recent ... and the technology-dominated Nasdaq saw a decrease of 3.07%. The the stock of drugstore chain and pharmacy benefits manager has risen by 2% in the ...

In this article, we are going to take a look at where CVS Health Corporation (NYSE:CVS) stands against the other stocks to buy and hold for 10 years. When the stock market experiences a sharp ...

Patient Capital Management also expressed bullish sentiments on the stock, saying that CVS Health Corporation (NYSE:CVS) has a diverse and attractive asset combination, including a pharmacy ...

GLP-1 drug prices are falling. That's good news for patients, but perhaps not such good news for pharmaceutical stock ...

Shares of CVS Health Corp. CVS soared toward a one-year high in early Thursday trading, after the healthcare-services company dropped a bombshell on investors — it’s leaving the Obamacare ...